Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dapagliflozin/metformin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dapagliflozin 5mg / Metformin 1g tablets
0601023ALAAABAB
|
Dapagliflozin/metformin | Dapagliflozin/metformin | Endocrine System | 20,583 |
|
Dapagliflozin 5mg / Metformin 850mg tablets
0601023ALAAAAAA
|
Dapagliflozin/metformin | Dapagliflozin/metformin | Endocrine System | 2,222 |
|
Xigduo 5mg/1000mg tablets
0601023ALBBABAB
|
Xigduo | Dapagliflozin/metformin | Endocrine System | 991 |
|
Xigduo 5mg/850mg tablets
0601023ALBBAAAA
|
Xigduo | Dapagliflozin/metformin | Endocrine System | 74 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.